Mandate

Vinge advises Edgeware AB (publ) in connection with listing on Nasdaq Stockholm

December 14, 2016

 Vinge has advised Edgeware AB (publ) (“Edgeware”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on 29 November 2016 and the first day of trading on Nasdaq was 9 December 2016. The offer price was set at SEK 29 per share, which corresponded to a market value for the total number of shares in the company of approximately MSEK 870. The total value of the offering amounted to MSEK 450 provided an overallotment option was exercised in its entirety.
 
Edgeware was founded in 2004 and has since evolved into a global, high-tech company that develops and offers hardware and software systems as well as associated services that enable effective and scalable TV and video streaming over IP. The Company’s solutions are primarily sold to telecom and cable operators as well as broadcasters and content owners that want to efficiently, securely and cost-efficiently make TV and video content available to their viewers.
 
Vinge’s team primarily consisted of Johan Larsson, Jesper Schönbeck, Rikard Lindahl, Johan Mattson, Amanda Knutsson, Malte Hedlund and Michaela Cronemyr. Tora Hansjons, Emilie Parland and Maria Schultzberg advised on tax issues.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025